Triple-negative breast cancer (TNBC) is characterized by a negative expression of the progesterone receptor (PR), the estrogen receptor (ER), and human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.